No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Center Laboratories, Inc. operates as a Taiwanese pharmaceutical enterprise, with its primary focus lying in the manufacturing and distribution of various medical products across Taiwan. Beyond its core drug operations, the firm is heavily invested in the research and development of both small molecule therapeutics and biologics, including proteins and antibodies. Additionally, its extensive portfolio encompasses pharmaceutical CDMO services, medical devices, nutritional health products, agribiotechnology initiatives, advanced stem cell and immune cell therapies, and even strategic ventures in industry investment funds and venture capital. Founded in 1959, Center Laboratories maintains its headquarters in Taipei, Taiwan.
www.centerlab.com.twNo one on the platform currently holds 4123.TWO.
No tracked institution reports a position in 4123.TWO as of their last filing.
No one on the platform has traded 4123.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4123.TWOCenter Laboratories, Inc. | $30.45 | +0.33% | $23.0B | — |
| 1707.TWGrape King Bio Ltd | $86.60 | +0.35% | $12.8B | — |
| 3705.TWYungShin Global Holding Corporation | $56.10 | +0.18% | $14.9B | — |
| 4105.TWOTTY Biopharm Company Limited | $78.40 | +0.13% | $19.5B | — |
| 4114.TWOSynmosa Biopharma Corporation | $29.45 | +0.34% | $15.9B | — |
| 6491.TWPegavision Corp. | $384.50 | -1.41% | $29.5B | — |
| 6550.TWPolaris Group | $9.99 | +0.91% | $8.9B | — |
Source: Financial Modeling Prep · peers by sector/industry